Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ENTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ENTA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Enanta Pharmaceuticals Inc

ENTA
Current price
7.12 USD +0.02 USD (+0.28%)
Last closed 7.18 USD
ISIN US29251M1062
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 154 552 816 USD
Yield for 12 month -41.73 %
1Y
3Y
5Y
10Y
15Y
ENTA
21.11.2021 - 28.11.2021

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts. Address: 4 Kingsbury Avenue, Watertown, MA, United States, 02472

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.20 USD

P/E ratio

Dividend Yield

Financials ENTA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ENTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+67 635 000 USD

Last Year

+79 204 000 USD

Current Quarter

+14 926 000 USD

Last Quarter

+16 959 000 USD

Current Year

+67 635 000 USD

Last Year

+79 204 000 USD

Current Quarter

+14 926 000 USD

Last Quarter

+16 959 000 USD
EBITDA -98 944 000 USD
Operating Margin TTM -164.32 %
Price to Earnings
Return On Assets TTM -17.33 %
PEG Ratio
Return On Equity TTM -74.27 %
Wall Street Target Price 15.20 USD
Revenue TTM 64 463 000 USD
Book Value 4.38 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -12.50 %
Dividend Yield
Gross Profit TTM 64 463 000 USD
Earnings per share -4.53 USD
Diluted Eps TTM -4.53 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -66.20 %
Profit Margin -149.57 %

Stock Valuation ENTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.31
Price Sales TTM 2.40
Enterprise Value EBITDA -0.29
Price Book MRQ 1.65

Technical indicators ENTA

For 52 weeks

4.09 USD 17.24 USD
50 Day MA 5.93 USD
Shares Short Prior Month 2 854 687
200 Day MA 7.74 USD
Short Ratio 22.35
Shares Short 2 721 617
Short Percent 13.53 %